20927-57-5 Usage
General Description
4-PHENYL-2,3-DIHYDRO-1H-1,5-BENZODIAZEPINE is a chemical compound belonging to the benzodiazepine class of psychoactive drugs. It is a derivative of the widely used anti-anxiety medication diazepam (Valium) and is known for its sedative and anxiolytic effects. 4-PHENYL-2,3-DIHYDRO-1H-1,5-BENZODIAZEPINE binds to the benzodiazepine receptor in the central nervous system, enhancing the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) to produce its calming and hypnotic effects. 4-PHENYL-2,3-DIHYDRO-1H-1,5-BENZODIAZEPINE is not approved for medical use and is classified as a controlled substance due to its potential for abuse and addiction. It is primarily used as a research chemical and for forensic purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 20927-57-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,2 and 7 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 20927-57:
(7*2)+(6*0)+(5*9)+(4*2)+(3*7)+(2*5)+(1*7)=105
105 % 10 = 5
So 20927-57-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H14N2/c1-2-6-12(7-3-1)13-10-11-16-14-8-4-5-9-15(14)17-13/h1-9,16H,10-11H2
20927-57-5Relevant articles and documents
Solid Phase Synthesis of Quinoxalines
Singh, Sanjay K.,Gupta, Priya,Duggineni, Srinivas,Kundu, Bijoy
, p. 2147 - 2150 (2003)
A versatile method for the solid phase synthesis of quinoxalines has been developed. Polymer-linked 2-nitrophenyl carbamate is treated with α-bromoketones followed by reduction of the nitro group, which underwent spontaneous intramolecular cyclization to afford polymer bound quinoxalines. Finally acidolytic cleavage gave the desired compounds via aerial oxidation in high yields and good purities.
Unexpected reaction of 3-benzoyl-4-hydroxy-1-methyl-4-phenylpiperidine with 1,2-diaminobenzene [4]
Soldatenkov,Kutyakov,Volkov,Mamyrbekova,Polyanski
, p. 1499 - 1501 (2007/10/03)
-
